REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $689,454 | -3.0% | 6,762 | -13.5% | 0.01% | 0.0% |
| Q1 2023 | $710,449 | +146.9% | 7,814 | +3.2% | 0.01% | +100.0% |
| Q4 2022 | $287,774 | +30.8% | 7,575 | +4.5% | 0.00% | +50.0% |
| Q2 2022 | $220,000 | -7.2% | 7,250 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $237,000 | -67.6% | 7,231 | -0.4% | 0.00% | -66.7% |
| Q3 2021 | $731,000 | -28.1% | 7,263 | +1.2% | 0.01% | -25.0% |
| Q2 2021 | $1,016,000 | +42.9% | 7,179 | +0.6% | 0.01% | +33.3% |
| Q1 2021 | $711,000 | -18.3% | 7,135 | +1.3% | 0.01% | -25.0% |
| Q4 2020 | $870,000 | +23.6% | 7,040 | -2.5% | 0.01% | +14.3% |
| Q3 2020 | $704,000 | -15.7% | 7,224 | +34.9% | 0.01% | -41.7% |
| Q2 2020 | $835,000 | +13.5% | 5,355 | +5.0% | 0.01% | -7.7% |
| Q1 2020 | $736,000 | – | 5,102 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $94,902,000 | 15.92% |
| Opaleye Management Inc. | 407,002 | $13,333,000 | 4.14% |
| Ikarian Capital, LLC | 649,600 | $21,281,000 | 2.80% |
| AWH Capital, L.P. | 150,000 | $2,459,457 | 2.54% |
| Boxer Capital, LLC | 1,239,000 | $40,590,000 | 2.09% |
| EcoR1 Capital, LLC | 1,975,611 | $64,721,000 | 2.02% |
| Camber Capital Management LP | 1,500,000 | $49,140,000 | 1.78% |
| MPM BioImpact LLC | 180,000 | $5,897,000 | 1.58% |
| Sofinnova Investments, Inc. | 602,545 | $19,739,000 | 1.50% |
| KRS Capital Management, LLC | 28,141 | $921,000 | 1.00% |